Endeavor Life Sciences adheres to a rigorous, multi-phase due diligence process that includes extensive corporate, market, and industry analysis.
Deal evaluation includes analysis of corporate management, corporate finances, assessment of underlying scientific and medical principles, clinical applications, clinical study design, drug and device approval feasibility, intellectual property, commercial application, pricing, reimbursement, and analysis of regulatory, legal, and economic changes that affect market dynamics and competitive landscapes.
Documents that we would like to have from our companies include:
– Executive Summary
– Business Plan
– Bio/CV for all senior management
– Cap Table
– Prior Term Sheets and Prospectus
– Financials
– Intellectual Property filings
– FDA and CMS history
– Strategic Partnership contracts
– Marketing and Sales contracts